|
Study | Treatment process | Treatment outcome |
|
Lipton and Stewart [24] | In terms of dosage form, the order of priority was tablets, nasal spray, and subcutaneous injection | Eighty-seven percent of patients had expected complete pain relief after treatment, 86% had no recurrence, and 83% had rapid pain relief |
Adelman et al. [25] | Among the included patients, 188 chose orally disintegrating tablets, while 179 preferred conventional tablets | |
Pascual et al. [26] | The reasons for patient preference for either of the two triptans were faster onset, duration of action, fewer adverse events, and lower price | |
Weidmann et al. [27] | In terms of dosage form, the order of priority was tablets, nasal spray, and subcutaneous injection | Rapid pain relief without adverse events |
Dahlöf et al. [28] | Most patients would like to continue using zolmitriptan nasal spray | Rapid pain relief without adverse events |
Lipton et al. [29] | When selecting a triptan, the rating of efficacy attributes was clearly more important than tolerability or consistency | Absence of pain within 1 hour was the most desired treatment outcome for migraine patients |
Schoenen et al. [30] | More patients preferred eletriptan | Rapid pain relief without recurrence |
Lainez et al. [31] | More patients preferred rizatriptan 10 mg wafer compared to eletriptan 40 mg tablets | Rapid pain relief and return to normal activities |
Dowson et al. [32] | At baseline, most patients indicated a preference for conventional tablets. After trying other formulations with a faster onset of action, most patients no longer preferred conventional tablets | Rapid pain relief |
Diez et al. [33] | More patients preferred almotriptan 12.5 mg compared to rizatriptan 10 mg | Rapid pain relief and return to normal activities |
Lanteri et al. [34] | Patients tended to use triptans and were satisfied with this treatment | Freedom from pain and rapid onset of action |
Bartolini et al. [35] | Most of the patients indicated a preference for triptans | Rapid pain relief without recurrence |
Gonzalez et al. [36]. | | No recurrence of headache |
Smelt et al. [37] | | Patients wanted to relieve pain within 30 minutes after treatment, returned to normal activity within 1 hour, and had no recurrence of headache |
|